[96a5a0]: / output / allTrials / identified / NCT05487248_identified.json

Download this file

653 lines (653 with data), 29.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
{
"info": {
"nct_id": "NCT05487248",
"official_title": "A Study of On-treatment CtDNA Changes in Chemo-refractory Colorectal Cancer Patients",
"inclusion_criteria": "1. Age ≥ 18 years old\n2. Male or female\n3. ECOG performance status ≤2\n4. Must have histologically or cytologically verified colorectal cancer adenocarcinoma\n5. Inoperable locally advanced or metastatic disease\n6. Presence of measurable disease (by RECIST criteria version 1.1) on baseline CT scan of the thorax/abdomen/pelvis or CT scan of the thorax and MRI of the abdomen/pelvis\n7. At least two prior systemic treatments for advanced/metastatic colorectal cancer including oxaliplatin and irinotecan-based therapy (adjuvant or neoadjuvant systemic chemotherapy will be considered if tumour progression was documented within 6 month of the last chemotherapy dose)\n8. Candidate for standard third-line or subsequent lines of therapy as per decision of the treating physician\n9. Life expectancy of at least 3 months\n10. Women of childbearing potential must have a negative serum pregnancy test done within 28 days prior to enrolment.\n11. Effective contraception is in place for women of childbearing potential.\n12. Completion of all necessary screening procedures within 28 days prior to enrolment.\n13. Availability of archived tumour tissue\n14. Signed Informed Consent form (ICF) obtained prior to any study related procedure.\n\n Inclusion criterion applicable to FRANCE only\n15. Affiliated to the French Social Security System\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Tumours other than colorectal cancer\n2. Histologies other than adenocarcinoma\n3. Any baseline medical condition that would contraindicate the use of systemic chemotherapy or may preclude the regular administration of the same\n4. Any psychiatric condition that would prohibit the understanding or rendering of informed consent\n5. Other invasive malignancy within 3 years except for non-invasive malignancies such as cervical carcinoma in situ, non-melanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has/have been surgically cured\n6. Subject with a significant medical, neuro-psychiatric, or surgical condition, currently uncontrolled by treatment, which, in the principal investigator's opinion, may interfere with completion of the study.\n7. Pregnant and/ or lactating women\n\n Exclusion criterion applicable to FRANCE only\n8. Vulnerable persons according to the article L.1121-6 of the Public Health Code, adults who are the subject of a measure of legal protection or unable to express their consent according to article L.1121-8 of the Public Health Code.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Age ≥ 18 years old",
"criterions": [
{
"exact_snippets": "Age ≥ 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "2. Male or female",
"criterions": [
{
"exact_snippets": "Male or female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "allowed_values",
"expected_value": [
"male",
"female"
]
}
]
}
]
},
{
"line": "3. ECOG performance status ≤2",
"criterions": [
{
"exact_snippets": "ECOG performance status ≤2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "4. Must have histologically or cytologically verified colorectal cancer adenocarcinoma",
"criterions": [
{
"exact_snippets": "histologically or cytologically verified colorectal cancer adenocarcinoma",
"criterion": "colorectal cancer adenocarcinoma",
"requirements": [
{
"requirement_type": "verification method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "5. Inoperable locally advanced or metastatic disease",
"criterions": [
{
"exact_snippets": "Inoperable locally advanced or metastatic disease",
"criterion": "disease operability",
"requirements": [
{
"requirement_type": "operability",
"expected_value": false
}
]
},
{
"exact_snippets": "Inoperable locally advanced or metastatic disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
}
]
},
{
"line": "6. Presence of measurable disease (by RECIST criteria version 1.1) on baseline CT scan of the thorax/abdomen/pelvis or CT scan of the thorax and MRI of the abdomen/pelvis",
"criterions": [
{
"exact_snippets": "Presence of measurable disease (by RECIST criteria version 1.1)",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "measurement criteria",
"expected_value": "RECIST criteria version 1.1"
}
]
},
{
"exact_snippets": "baseline CT scan of the thorax/abdomen/pelvis or CT scan of the thorax and MRI of the abdomen/pelvis",
"criterion": "imaging requirement",
"requirements": [
{
"requirement_type": "imaging type",
"expected_value": [
"CT scan of the thorax/abdomen/pelvis",
"CT scan of the thorax and MRI of the abdomen/pelvis"
]
},
{
"requirement_type": "timing",
"expected_value": "baseline"
}
]
}
]
},
{
"line": "7. At least two prior systemic treatments for advanced/metastatic colorectal cancer including oxaliplatin and irinotecan-based therapy (adjuvant or neoadjuvant systemic chemotherapy will be considered if tumour progression was documented within 6 month of the last chemotherapy dose)",
"criterions": [
{
"exact_snippets": "At least two prior systemic treatments for advanced/metastatic colorectal cancer",
"criterion": "prior systemic treatments",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "treatments"
}
}
]
},
{
"exact_snippets": "including oxaliplatin and irinotecan-based therapy",
"criterion": "prior systemic treatments",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": [
"oxaliplatin",
"irinotecan-based therapy"
]
}
]
},
{
"exact_snippets": "adjuvant or neoadjuvant systemic chemotherapy will be considered if tumour progression was documented within 6 month of the last chemotherapy dose",
"criterion": "tumour progression",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": "within 6 months of the last chemotherapy dose"
}
]
}
]
},
{
"line": "8. Candidate for standard third-line or subsequent lines of therapy as per decision of the treating physician",
"criterions": [
{
"exact_snippets": "Candidate for standard third-line or subsequent lines of therapy",
"criterion": "therapy line",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": "third-line or subsequent lines"
}
]
},
{
"exact_snippets": "as per decision of the treating physician",
"criterion": "physician decision",
"requirements": [
{
"requirement_type": "approval",
"expected_value": true
}
]
}
]
},
{
"line": "9. Life expectancy of at least 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy of at least 3 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "10. Women of childbearing potential must have a negative serum pregnancy test done within 28 days prior to enrolment.",
"criterions": [
{
"exact_snippets": "Women of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "negative serum pregnancy test",
"criterion": "serum pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "done within 28 days prior to enrolment",
"criterion": "serum pregnancy test timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "within 28 days prior to enrolment"
}
]
}
]
},
{
"line": "11. Effective contraception is in place for women of childbearing potential.",
"criterions": [
{
"exact_snippets": "Effective contraception is in place for women of childbearing potential.",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": true
}
]
},
{
"exact_snippets": "women of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "gender",
"expected_value": "female"
}
]
}
]
},
{
"line": "12. Completion of all necessary screening procedures within 28 days prior to enrolment.",
"criterions": [
{
"exact_snippets": "Completion of all necessary screening procedures",
"criterion": "screening procedures",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "within 28 days prior to enrolment",
"criterion": "screening procedures",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
]
}
]
},
{
"line": "13. Availability of archived tumour tissue",
"criterions": [
{
"exact_snippets": "Availability of archived tumour tissue",
"criterion": "archived tumour tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
}
]
},
{
"line": "14. Signed Informed Consent form (ICF) obtained prior to any study related procedure.",
"criterions": [
{
"exact_snippets": "Signed Informed Consent form (ICF) obtained",
"criterion": "informed consent form",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
},
{
"requirement_type": "obtained",
"expected_value": true
}
]
}
]
},
{
"line": "Inclusion criterion applicable to FRANCE only",
"criterions": [
{
"exact_snippets": "applicable to FRANCE only",
"criterion": "geographic location",
"requirements": [
{
"requirement_type": "location",
"expected_value": "FRANCE"
}
]
}
]
},
{
"line": "15. Affiliated to the French Social Security System",
"criterions": [
{
"exact_snippets": "Affiliated to the French Social Security System",
"criterion": "French Social Security System affiliation",
"requirements": [
{
"requirement_type": "affiliation",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Tumours other than colorectal cancer",
"criterions": [
{
"exact_snippets": "Tumours other than colorectal cancer",
"criterion": "tumours",
"requirements": [
{
"requirement_type": "type",
"expected_value": {
"operator": "!=",
"value": 1,
"unit": "colorectal cancer"
}
}
]
}
]
},
{
"line": "2. Histologies other than adenocarcinoma",
"criterions": [
{
"exact_snippets": "Histologies other than adenocarcinoma",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": {
"operator": "!=",
"value": 1,
"unit": "adenocarcinoma"
}
}
]
}
]
},
{
"line": "3. Any baseline medical condition that would contraindicate the use of systemic chemotherapy or may preclude the regular administration of the same",
"criterions": [
{
"exact_snippets": "baseline medical condition that would contraindicate the use of systemic chemotherapy",
"criterion": "baseline medical condition",
"requirements": [
{
"requirement_type": "contraindication",
"expected_value": "systemic chemotherapy"
}
]
},
{
"exact_snippets": "baseline medical condition that ... may preclude the regular administration of the same",
"criterion": "baseline medical condition",
"requirements": [
{
"requirement_type": "preclusion",
"expected_value": "regular administration of systemic chemotherapy"
}
]
}
]
},
{
"line": "4. Any psychiatric condition that would prohibit the understanding or rendering of informed consent",
"criterions": [
{
"exact_snippets": "psychiatric condition that would prohibit the understanding or rendering of informed consent",
"criterion": "psychiatric condition",
"requirements": [
{
"requirement_type": "impact on informed consent",
"expected_value": "prohibitive"
}
]
}
]
},
{
"line": "5. Other invasive malignancy within 3 years except for non-invasive malignancies such as cervical carcinoma in situ, non-melanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has/have been surgically cured",
"criterions": [
{
"exact_snippets": "Other invasive malignancy within 3 years",
"criterion": "invasive malignancy",
"requirements": [
{
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "years"
}
}
]
},
{
"exact_snippets": "except for non-invasive malignancies such as cervical carcinoma in situ, non-melanomatous carcinoma of the skin or ductal carcinoma in situ of the breast",
"criterion": "non-invasive malignancies",
"requirements": [
{
"requirement_type": "types",
"expected_value": [
"cervical carcinoma in situ",
"non-melanomatous carcinoma of the skin",
"ductal carcinoma in situ of the breast"
]
}
]
},
{
"exact_snippets": "that has/have been surgically cured",
"criterion": "surgical cure",
"requirements": [
{
"requirement_type": "status",
"expected_value": "cured"
}
]
}
]
},
{
"line": "6. Subject with a significant medical, neuro-psychiatric, or surgical condition, currently uncontrolled by treatment, which, in the principal investigator's opinion, may interfere with completion of the study.",
"criterions": [
{
"exact_snippets": "significant medical, neuro-psychiatric, or surgical condition",
"criterion": "medical, neuro-psychiatric, or surgical condition",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
},
{
"exact_snippets": "currently uncontrolled by treatment",
"criterion": "condition control",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "7. Pregnant and/ or lactating women",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating women",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "Exclusion criterion applicable to FRANCE only",
"criterions": [
{
"exact_snippets": "Exclusion criterion applicable to FRANCE only",
"criterion": "geographic location",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": "FRANCE"
}
]
}
]
},
{
"line": "8. Vulnerable persons according to the article L.1121-6 of the Public Health Code, adults who are the subject of a measure of legal protection or unable to express their consent according to article L.1121-8 of the Public Health Code.",
"criterions": [
{
"exact_snippets": "Vulnerable persons according to the article L.1121-6 of the Public Health Code",
"criterion": "vulnerable persons",
"requirements": [
{
"requirement_type": "legal definition",
"expected_value": "article L.1121-6 of the Public Health Code"
}
]
},
{
"exact_snippets": "adults who are the subject of a measure of legal protection",
"criterion": "legal protection",
"requirements": [
{
"requirement_type": "status",
"expected_value": "subject of a measure of legal protection"
}
]
},
{
"exact_snippets": "unable to express their consent according to article L.1121-8 of the Public Health Code",
"criterion": "ability to express consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
},
{
"requirement_type": "legal definition",
"expected_value": "article L.1121-8 of the Public Health Code"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}